{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:16:13Z","timestamp":1792077373204,"version":"4.4.0"},"update-to":[{"DOI":"10.1371\/journal.pmed.1004239","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000}}],"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1190803"],"award-info":[{"award-number":["OPP1190803"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006734","name":"Princeton University","doi-asserted-by":"publisher","award":["Smith-Newton Environmental Scholarship"],"award-info":[{"award-number":["Smith-Newton Environmental Scholarship"]}],"id":[{"id":"10.13039\/100006734","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["21IPA2113462"],"award-info":[{"award-number":["21IPA2113462"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CCF1918628"],"award-info":[{"award-number":["CCF1918628"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Despite significant global progress in reducing neonatal mortality, bacterial sepsis remains a major cause of neonatal deaths. <jats:italic>Klebsiella pneumoniae<\/jats:italic> (<jats:italic>K<\/jats:italic>. <jats:italic>pneumoniae<\/jats:italic>) is the leading pathogen globally underlying cases of neonatal sepsis and is frequently resistant to antibiotic treatment regimens recommended by the World Health Organization (WHO), including first-line therapy with ampicillin and gentamicin, second-line therapy with amikacin and ceftazidime, and meropenem. Maternal vaccination to prevent neonatal infection could reduce the burden of <jats:italic>K<\/jats:italic>. <jats:italic>pneumoniae<\/jats:italic> neonatal sepsis in low- and middle-income countries (LMICs), but the potential impact of vaccination remains poorly quantified. We estimated the potential impact of such vaccination on cases and deaths of <jats:italic>K<\/jats:italic>. <jats:italic>pneumoniae<\/jats:italic> neonatal sepsis and project the global effects of routine immunization of pregnant women with the <jats:italic>K<\/jats:italic>. <jats:italic>pneumoniae<\/jats:italic> vaccine as antimicrobial resistance (AMR) increases.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and findings<\/jats:title>\n<jats:p>We developed a Bayesian mixture-modeling framework to estimate the effects of a hypothetical <jats:italic>K<\/jats:italic>. <jats:italic>pneumoniae<\/jats:italic> maternal vaccine with 70% efficacy administered with coverage equivalent to that of the maternal tetanus vaccine on neonatal sepsis infections and mortality. To parameterize our model, we used data from 3 global studies of neonatal sepsis and\/or mortality\u2014with 2,330 neonates who died with sepsis surveilled from 2016 to 2020 undertaken in 18 mainly LMICs across all WHO regions (Ethiopia, Kenya, Mali, Mozambique, Nigeria, Rwanda, Sierra Leone, South Africa, Uganda, Brazil, Italy, Greece, Pakistan, Bangladesh, India, Thailand, China, and Vietnam). Within these studies, 26.95% of fatal neonatal sepsis cases were culture-positive for <jats:italic>K<\/jats:italic>. <jats:italic>pneumoniae<\/jats:italic>. We analyzed 9,070 <jats:italic>K<\/jats:italic>. <jats:italic>pneumoniae<\/jats:italic> genomes from human isolates gathered globally from 2001 to 2020 to quantify the temporal rate of acquisition of AMR genes in <jats:italic>K<\/jats:italic>. <jats:italic>pneumoniae<\/jats:italic> isolates to predict the future number of drug-resistant cases and deaths that could be averted by vaccination.<\/jats:p>\n<jats:p>Resistance rates to carbapenems are increasing most rapidly and 22.43% [95th percentile Bayesian credible interval (CrI): 5.24 to 41.42] of neonatal sepsis deaths are caused by meropenem-resistant <jats:italic>K<\/jats:italic>. <jats:italic>pneumoniae<\/jats:italic>. Globally, we estimate that maternal vaccination could avert 80,258 [CrI: 18,084 to 189,040] neonatal deaths and 399,015 [CrI: 334,523 to 485,442] neonatal sepsis cases yearly worldwide, accounting for more than 3.40% [CrI: 0.75 to 8.01] of all neonatal deaths. The largest relative benefits are in Africa (Sierra Leone, Mali, Niger) and South-East Asia (Bangladesh) where vaccination could avert over 6% of all neonatal deaths. Nevertheless, our modeling only considers country-level trends in <jats:italic>K<\/jats:italic>. <jats:italic>pneumoniae<\/jats:italic> neonatal sepsis deaths and is unable to consider within-country variability in bacterial prevalence that may impact the projected burden of sepsis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>A <jats:italic>K<\/jats:italic>. <jats:italic>pneumoniae<\/jats:italic> maternal vaccine could have widespread, sustained global benefits as AMR in <jats:italic>K<\/jats:italic>. <jats:italic>pneumoniae<\/jats:italic> continues to increase.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pmed.1004239","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T17:31:55Z","timestamp":1684776715000},"page":"e1004239","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":54,"title":["Global, regional, and national estimates of the impact of a maternal Klebsiella pneumoniae vaccine: A Bayesian modeling analysis"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1542-8643","authenticated-orcid":true,"given":"Chirag K.","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5049-4481","authenticated-orcid":true,"given":"Kirsty","family":"Sands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seamus","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Sharland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Lewnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmini","family":"Srikantiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1390-9016","authenticated-orcid":true,"given":"Ramanan","family":"Laxminarayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,5,22]]},"reference":[{"issue":"9966","key":"pmed.1004239.ref001","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0140-6736(14)61698-6","article-title":"Global, regional, and national causes of child mortality in 2000\u201313, with projections to inform post-2015 priorities: an updated systematic analysis","volume":"385","author":"L Liu","year":"2015","journal-title":"Lancet"},{"issue":"11","key":"pmed.1004239.ref002","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S1473-3099(19)30414-1","article-title":"Aetiology of invasive bacterial infection and antimicrobial resistance in neonates in sub-Saharan Africa: a systematic review and meta-analysis in line with the STROBE-NI reporting guidelines","volume":"19","author":"U Okomo","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"pmed.1004239.ref003","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1473-3099(14)70804-7","article-title":"Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, south Asia, and Latin America for 2012: a systematic review and meta-analysis","volume":"14","author":"AC Seale","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"pmed.1004239.ref004","doi-asserted-by":"crossref","first-page":"e909","DOI":"10.1016\/S2214-109X(20)30205-9","article-title":"Initial findings from a novel population-based child mortality surveillance approach: a descriptive study","volume":"8","author":"AW Taylor","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"4","key":"pmed.1004239.ref005","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41564-021-00870-7","article-title":"Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries.","volume":"6","author":"BARNARDS Group","year":"2021","journal-title":"Nat Microbiol."},{"key":"pmed.1004239.ref006","doi-asserted-by":"crossref","first-page":"k5314","DOI":"10.1136\/bmj.k5314","article-title":"Neonatal sepsis in South Asia: huge burden and spiralling antimicrobial resistance","volume":"364","author":"S Chaurasia","year":"2019","journal-title":"BMJ"},{"issue":"12","key":"pmed.1004239.ref007","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S1473-3099(21)00050-5","article-title":"Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS).","volume":"21","author":"KM Thomson","year":"2021","journal-title":"Lancet Infect Dis."},{"key":"pmed.1004239.ref008","volume-title":"Antimicrobial resistance and primary health care","author":"World Health Organization","year":"2018"},{"issue":"3","key":"pmed.1004239.ref009","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.gheart.2014.08.009","article-title":"Antibiotic use and emerging resistance: how can resource-limited countries turn the tide","volume":"9","author":"LM Bebell","year":"2014","journal-title":"Glob Heart"},{"issue":"7","key":"pmed.1004239.ref010","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/14760584.2019.1635460","article-title":"Progress towards the development of Klebsiella vaccines","volume":"18","author":"M Choi","year":"2019","journal-title":"Expert Rev Vaccines"},{"issue":"37","key":"pmed.1004239.ref011","doi-asserted-by":"crossref","first-page":"18655","DOI":"10.1073\/pnas.1907833116","article-title":"A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae","volume":"116","author":"MF Feldman","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"pmed.1004239.ref012","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/clinids\/23.1.179","article-title":"Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma","volume":"23","author":"WN Campbell","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"14","key":"pmed.1004239.ref013","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0264-410X(94)80054-4","article-title":"Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously","volume":"12","author":"R Edelman","year":"1994","journal-title":"Vaccine"},{"issue":"3","key":"pmed.1004239.ref014","article-title":"Kaptive 2.0: updated capsule and lipopolysaccharide locus typing for the Klebsiella pneumoniae species complex","volume":"8","author":"MM Lam","year":"2022","journal-title":"Microb Genomics"},{"issue":"6","key":"pmed.1004239.ref015","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41590-018-0106-2","article-title":"Cross-specificity of protective human antibodies against Klebsiella pneumoniae LPS O-antigen","volume":"19","author":"T Rollenske","year":"2018","journal-title":"Nat Immunol"},{"issue":"6","key":"pmed.1004239.ref016","doi-asserted-by":"crossref","first-page":"e02994","DOI":"10.1128\/mBio.02994-19","article-title":"Vaccine protection against multidrug-resistant Klebsiella pneumoniae in a nonhuman primate model of severe lower respiratory tract infection","volume":"10","author":"N Malachowa","year":"2019","journal-title":"MBio"},{"issue":"1","key":"pmed.1004239.ref017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-02223-7","article-title":"Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae.","volume":"8","author":"ME Pennini","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"pmed.1004239.ref018","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1186\/s12879-019-4541-y","article-title":"Active immunoprophyilaxis with uromune decreases the recurrence of urinary tract infections at three and six months after treatment without relevant secondary effects.","volume":"19","author":"C Ram\u00edrez Sevilla","year":"2019","journal-title":"BMC Infect Dis."},{"issue":"7","key":"pmed.1004239.ref019","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1080\/21505594.2017.1279778","article-title":"Endotoxin neutralization by an O-antigen specific monoclonal antibody: a potential novel therapeutic approach against Klebsiella pneumoniae ST258.","volume":"8","author":"V Szij\u00e1rt\u00f3","year":"2017","journal-title":"Virulence."},{"issue":"9603","key":"pmed.1004239.ref020","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0140-6736(07)61261-6","article-title":"Maternal and neonatal tetanus","volume":"370","author":"MH Roper","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"pmed.1004239.ref021","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1093\/cid\/cix653","article-title":"Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates","volume":"65","author":"JE Lawn","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"18","key":"pmed.1004239.ref022","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJMra012493","article-title":"Maternal antibodies, childhood infections, and autoimmune diseases","volume":"345","author":"RM Zinkernagel","year":"2001","journal-title":"N Engl J Med"},{"issue":"7806","key":"pmed.1004239.ref023","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-2238-4","article-title":"Childhood vaccines and antibiotic use in low- and middle-income countries","volume":"581","author":"JA Lewnard","year":"2020","journal-title":"Nature"},{"issue":"13","key":"pmed.1004239.ref024","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/0264-410X(92)90327-G","article-title":"The concept of herd immunity and the design of community-based immunization programmes","volume":"10","author":"RM Anderson","year":"1992","journal-title":"Vaccine"},{"issue":"6","key":"pmed.1004239.ref025","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/INF.0000000000000692","article-title":"Empiric treatment of neonatal sepsis in developing countries.","volume":"34","author":"CW Obiero","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"pmed.1004239.ref026","article-title":"Patterns of antibiotic use, pathogens and clinical outcomes in hospitalised neonates and young infants with sepsis in the NeoOBS global neonatal sepsis observational cohort study.","author":"NJ Russell","year":"2022","journal-title":"medRxiv."},{"issue":"2","key":"pmed.1004239.ref027","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/00401706.1987.10488205","article-title":"Large Sample Properties of Simulations Using Latin Hypercube Sampling","volume":"29","author":"M. Stein","year":"1987","journal-title":"Technometrics."},{"issue":"10258","key":"pmed.1004239.ref028","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"396","author":"CJL Murray","year":"2020","journal-title":"Lancet"},{"issue":"10325","key":"pmed.1004239.ref029","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.","volume":"399","author":"CJ Murray","year":"2022","journal-title":"Lancet"},{"issue":"24","key":"pmed.1004239.ref030","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1016\/S0264-410X(03)00347-5","article-title":"Tetanus in developing countries: an update on the Maternal and Neonatal Tetanus Elimination Initiative","volume":"21","author":"J Vandelaer","year":"2003","journal-title":"Vaccine"},{"issue":"4","key":"pmed.1004239.ref031","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.1093\/cid\/ciab784","article-title":"Rapid genomic characterization and global surveillance of Klebsiella using pathogenwatch","volume":"73","author":"S Argim\u00f3n","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"9","key":"pmed.1004239.ref032","doi-asserted-by":"crossref","first-page":"e1003787","DOI":"10.1371\/journal.pmed.1003787","article-title":"Gram-negative neonatal sepsis in low- and lower-middle-income countries and WHO empirical antibiotic recommendations: A systematic review and meta-analysis.","volume":"18","author":"SCH Wen","year":"2021","journal-title":"PLoS Med."},{"issue":"1","key":"pmed.1004239.ref033","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41467-020-20731-x","article-title":"Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccine","volume":"12","author":"H Fu","year":"2021","journal-title":"Nat Commun"},{"key":"pmed.1004239.ref034","article-title":"Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study.","author":"R Birger","year":"2022","journal-title":"Lancet Infect Dis."},{"issue":"8","key":"pmed.1004239.ref035","doi-asserted-by":"crossref","first-page":"e1170","DOI":"10.1016\/S2214-109X(22)00246-7","article-title":"Culture-confirmed neonatal bloodstream infections and meningitis in South Africa, 2014\u201319: a cross-sectional study.","volume":"10","author":"RC Mashau","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"10","key":"pmed.1004239.ref036","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1016\/S2214-109X(16)30148-6","article-title":"Investigators of the Delhi Neonatal Infection Study (DeNIS) collaboration. Characterization and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study","volume":"4","author":"S Chaurasia","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"1","key":"pmed.1004239.ref037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/tropej\/fmu079","article-title":"Challenges in the diagnosis and management of neonatal sepsis.","volume":"61","author":"A Zea-Vera","year":"2015","journal-title":"J Trop Pediatr."},{"issue":"1","key":"pmed.1004239.ref038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12961-018-0338-5","article-title":"Gendered health systems: evidence from low-and middle-income countries.","volume":"16","author":"R Morgan","year":"2018","journal-title":"Health Res Policy Syst"}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1004239","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T18:25:43Z","timestamp":1686853543000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,22]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004239","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pmed.1004239","asserted-by":"object"}]},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,22]]}}}